Traditional aqueous kava extracts inhibit cytochrome P450 1A2 in humans: Protective effect against environmental carcinogens? [3]

Clinical Pharmacology and Therapeutics

Volumn 77, Issue 5, 2005, Pages 453-454

  Russmann, Stefan ^a   Lauterburg, Bernhard H ^a   Barguil, Yann ^b   Choblet, Erwan ^b   Cabalion, Pierre ^c   Rentsch, Katharina ^d   Wenk, Markus ^e  

^a UNIVERSITY OF BERN   (Switzerland)

^b New Caledonia Hospital Center   (New Caledonia)

^c Institute of Research and Development   (New Caledonia)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CARCINOGEN; CHLORZOXAZONE; CYTOCHROME P450 1A2; DEBRISOQUINE; KAVA EXTRACT; KAVALACTONE; MEPHENYTOIN; MIDAZOLAM; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; KAVA; PLANT EXTRACT; WATER;

ADULT; AQUEOUS SOLUTION; CIGARETTE SMOKING; CONTROLLED STUDY; DRINKING; DRUG EFFECT; ENVIRONMENTAL PROTECTION; ENZYME INHIBITION; FEMALE; HUMAN; LETTER; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TRADITIONAL MEDICINE; CHEMISTRY; DRUG ANTAGONISM; DRUG SELF ADMINISTRATION; ETHNOLOGY; FORECASTING; METABOLISM; NEW CALEDONIA; NOTE; ORIENTAL MEDICINE; TIME; UPREGULATION;

CARCINOGENS, ENVIRONMENTAL; CYTOCHROME P-450 CYP1A2; FEMALE; FORECASTING; HUMANS; KAVA; MALE; MEDICINE, ORIENTAL TRADITIONAL; NEW CALEDONIA; PLANT EXTRACTS; SELF ADMINISTRATION; TIME FACTORS; UP-REGULATION; WATER;

EID: 19144365783     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2005.01.021     Document Type: Letter

References (6)

1. S.M. Huang, S.D. Hall, P. Watkins, L.A. Love, C. Serabjit-Singh, J.M. Betz Drug interactions with herbal products and grapefruit juice a conference report Clin Pharmacol Ther 75 2004 1 12
2. J.M. Mathews, A.S. Etheridge, S.R. Black Inhibition of human cytochrome P450 activities by kava extract and kavalactones Drug Metab Dispos 30 2002 1153 1157
3. Y. Barguil, A. Mandeau, J. Collignon, K. Beata, D. Duhet Identification de kavalactones dans le sang, la salive et l'urine par CLHP/BD, approche cinétique et application à la toxicologie clinique et médico-légale [abstract] Annal Toxicol Anal 13 2001 139
4. B.J. Gurley, S.F. Gardner, M.A. Hubbard, D.K. Williams, W.B. Gentry, Y. Cui Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans Clin Pharmacol Ther 72 2002 276 287
5. G.E. Blakey, J.A. Lockton, J. Perrett, P. Norwood, M. Russell, Z. Aherne Pharmacokinetic and pharmacodynamic assessment of a five-probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1 Br J Clin Pharmacol 57 2004 162 169
6. G.G. Steiner The correlation between cancer incidence and kava consumption Hawaii Med J 59 2000 420 422